DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Elekta Unity MR-linac gains FDA 510(k) clearance Simultaneously delivers radiation dose and visualization of tumors

Dr. Hermann Requardt United Imaging Healthcare appoints senior scientific advisor

Patient denied proton therapy dies, family received $25 million in court Points to the need for greater treatment coverage for certain cancer patients

Microbeam radiation therapy could lead to single session treatments Healthy cells tolerate treatment while tumors lose structure

CMS to unveil mandatory payment model for radiation oncology Part of determining approach that saves more and offers greater quality

European report says radiotherapy 'undervalued' and needing 'greater investment' Equipment shortages, lack of investment, training variations

ViewRay to supply UK's GenesisCare with country's first MRIdian systems Providing soft-tissue imaging in real time and better tumor targeting

Accuray showcases software upgrades for CyberKnife and Radixact at ASTRO Allows for 40 percent faster treatment delivery

Precision cancer care with proton and radiation oncology Some of the latest systems and software entering the market

IBA Dosimetry debuts myQA Daily at ASTRO 2018 Has 125 ionization chamber measurement points

International group calls for global standards for scanning cancer biomarkers

by John W. Mitchell , Senior Correspondent
In a sweeping review of some of the most promising modern therapies, an international panel lead by Cancer Research UK (CRUK) has made 14 recommendations to raise the bar on the effectiveness of cancer research — and imaging factors in significantly.

"Scientists generate many great new ideas every year that use imaging to try to detect cancer earlier, to better assess if therapies are working well in patients, and to select which patients should receive new therapies that have been developed in clinical trials," James O'Connor, Ph.D., one of the panel members and a scientist at CRUK, Manchester Institute, University of Manchester, U.K., told HCB News.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



He added that "far too few" of these ideas get turned into tests, known as biomarkers, that are used by doctors to help guide patient treatment.

"We assembled 78 experts from across Europe and North America to identify the reasons why imaging tests have not made as great an impact as they could to provide a framework — or roadmap — to help accelerate the translation of these science ideas into validated tests," said O'Connor.

The group, which includes members from Harvard Medical School, University of Michigan Health System, Moffitt Cancer Center, Johns Hopkins Medicine and Duke University School of Medicine, published their findings in Nature Reviews Clinical Oncology.

Among other things, the group offered recommendations for grant submissions, for making sure results are reproducible across laboratories, for comparing scans with other tests such as liquid biopsy, and ensuring that techniques are cost-effective. The group also suggests coordinating calibration among different imaging equipment makers to standardize data for use in research.

The study noted that in countries with the best cancer outcomes, 60 percent of patients receive radiation therapy and it is one of the most cost-effective treatments.

There have been significant technology advances, such as image-guided radiation therapy, intensity-modulated radiation therapy, stereotactic treatment and proton therapy to better target the cancer and reduce exposure to surrounding cells. However, aside from the combination of traditional chemotherapy, little progress has been made defining optimal targeted therapy and radiation to improve the efficacy of cancer treatment.

“If these recommendations raise the bar in imaging research, we can expect scans to play a much greater role in personalized medicine and to further improve the lives of patients, with cancer having cutting edge therapies," said O'Connor.

Back to HCB News
  Pages: 1

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED